Form 4: DENTSPLY SIRONA CEO Boosts Phantom Stock Holdings

DENTSPLY SIRONA's President and CEO, Daniel T. Scavilla, acquired 3,554.869 shares of phantom stock under the company's Supplemental Executive Retirement Plan.

Summary

• Daniel T. Scavilla, President, CEO, and Member of the Board of Directors of DENTSPLY SIRONA Inc. (XRAY), acquired 3,554.869 shares of phantom stock.
• The acquisition occurred on March 11, 2026, as part of a Supplemental Executive Retirement Plan (SERP) contribution for the year 2025.
• Each share of phantom stock is the economic equivalent of one share of common stock.
• The phantom stock units were valued at $11.43 per unit, based on the closing price as of December 31, 2025.
• These phantom stock shares will become payable in common stock upon Mr. Scavilla's termination of employment.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting continued executive alignment with shareholder interests through a long-term incentive plan, which is a standard and healthy corporate governance practice.

Positives

• The acquisition of phantom stock aligns the long-term interests of the CEO with those of shareholders, as the value of the phantom stock is tied to the company's common stock performance.
• Participation in the Supplemental Executive Retirement Plan (SERP) indicates a structured approach to executive compensation and retention.

Negatives

• The phantom stock is not immediately convertible to common stock and only becomes payable upon termination of employment, meaning it does not represent immediate liquidity or direct voting rights for the executive.

Future Outlook

The phantom stock units are designed to become payable in common stock upon the reporting person's termination of employment, indicating a long-term incentive structure tied to future company performance and executive tenure.

Industry Context

StockSavvy.ai notes that the grant of phantom stock under a Supplemental Executive Retirement Plan (SERP) is a common form of executive compensation in many industries, including the dental products and technology sector where DENTSPLY SIRONA operates. Such plans are designed to retain key executives and align their long-term financial interests with shareholder value creation.

Comparison to Industry Standards

• Executive compensation structures, including phantom stock grants and SERPs, are standard practice across publicly traded companies, particularly for C-suite executives.
• Companies like Align Technology (ALGN) and Henry Schein (HSIC), competitors in the dental industry, also utilize various forms of equity-based compensation to incentivize and retain their leadership.

Stakeholder Impact

• Shareholders: The grant of phantom stock aligns the CEO's long-term financial interests with the company's stock performance, potentially encouraging decisions that enhance shareholder value.
• Employees: This transaction specifically relates to executive compensation and does not directly impact the broader employee base, though it reflects the company's overall compensation philosophy for leadership.

Next Steps

• The phantom stock will become payable in common stock upon Daniel T. Scavilla's termination of employment.

Key Dates

Keywords

DENTSPLY SIRONA, XRAY, Daniel T. Scavilla, Phantom Stock, SERP, Executive Compensation, Insider Transaction, Form 4, Beneficial Ownership